Non-toxic larvicide

US11337422B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11337422-B2
Application numberUS-201916520847-A
CountryUS
Kind codeB2
Filing dateJul 24, 2019
Priority dateApr 17, 2015
Publication dateMay 24, 2022
Grant dateMay 24, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A larvicide comprising an essential oil encapsulated within a non-viable yeast cell. The larvicide is particularly effective against mosquito larvae, non-toxic to humans and other non-target species, inexpensive to make, and non-toxic during manufacture, transport, and storage.

First claim

Opening claim text (preview).

What is claimed is: 1. A larvicidal capsule comprising an essential oil encapsulated in a non-viable intact ingestible yeast cell delivery vehicle, wherein said essential oil is selected from the group consisting of mandarin orange oil, sweet orange oil, clove bud oil, primary compounds thereof or a mixture thereof, wherein the capsule does not contain any essential oil, primary compounds thereof and does not have a soluble silica coating on the external surface, and wherein the yeast cell delivery vehicle sequesters the oil from a surrounding environment until the yeast cell delivery vehicle is ingested by larvae of the pest insect. 2. The larvicidal capsule of claim 1 wherein said essential oil is mandarin orange oil. 3. The larvicidal capsule of claim 1 wherein said essential oil is sweet orange oil. 4. The larvicidal capsule of claim 1 wherein said essential oil is clove bud oil. 5. The larvicidal capsule of claim 1 further comprising a buoyancy control mechanism. 6. The larvicidal capsule of claim 5 wherein the buoyancy control mechanism comprises an air pocket within the non-viable yeast cell. 7. The larvicidal capsule of claim 6 wherein the air pocket maintains the larvicidal capsule on the surface of the body of water. 8. The larvicidal capsule of claim 6 wherein the air pocket maintains the larvicidal capsule below the surface of the body of water but above the bottom of the body of water. 9. The larvicidal capsule of claim 1 further comprising an adhesive element that facilitates clumping of multiple larvicidal capsules. 10. The larvicidal capsule of claim 9 wherein the adhesive element is applied to the exterior of the ingestible delivery vehicle. 11. The larvicidal capsule of claim 5 further comprising an adhesive element that facilitates clumping of multiple larvicidal capsules. 12. A composition comprising a population of larvicide capsules according to claim 1 . 13. A method for controlling a target pest population comprising; introducing to the target pest population the larvicidal capsule of claim 1 under suitable conditions such that it is likely that larvae of said target pest population will ingest the larvicidal capsule. 14. The method of claim 13 wherein said introducing comprises positioning a powder comprising the larvicidal capsules in an area wherein gravid adult female target pests are likely to congregate, wherein the powder adheres to the gravid female such that it is carried to oviposition sites. 15. A method for forming a larvicidal capsule comprising encapsulating an essential oil within a non-viable ingestible intact yeast cell delivery vehicle, wherein said essential oil is selected from the group consisting of mandarin orange oil, sweet orange oil, clove bud oil, primary compounds thereof or a mixture thereof and washing said delivery vehicle with a surfactant after encapsulation to remove essential oil and primary compounds thereof from the surface of said capsule, wherein the capsule does not have a soluble silica coating, and wherein the yeast cell delivery vehicle sequesters the oil from a surrounding environment until the yeast cell delivery vehicle is ingested by larvae of the pest insect. 16. The method of claim 15 further comprising introducing a buoyancy control mechanism into the larvicidal capsule.

Assignees

Inventors

Classifications

  • Rutaceae [Rue family], e.g. lime, orange, lemon, corktree or pricklyash · CPC title

  • A01N25/28Primary

    Microcapsules {or nanocapsules} · CPC title

  • Myrtaceae [Myrtle family], e.g. teatree or clove · CPC title

  • Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title

  • Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof (containing compounds of determined constitution A01N27/00 - A01N59/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11337422B2 cover?
A larvicide comprising an essential oil encapsulated within a non-viable yeast cell. The larvicide is particularly effective against mosquito larvae, non-toxic to humans and other non-target species, inexpensive to make, and non-toxic during manufacture, transport, and storage.
Who is the assignee on this patent?
Unm Rainforest Innovations
What technology area does this patent fall under?
Primary CPC classification A01N25/28. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).